• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sage Bionetworks Receives Quintiles Donation

Sage Bionetworks Receives Quintiles Donation

October 14, 2009
CenterWatch Staff

Sage Bionetworks, a not-for-profit organization established to develop an open-access genomic platform for use in drug discovery, has received a major donation from Quintiles, a contract research organization (CRO).

The size of the donation was not disclosed. The Quintiles donation is a major part of Sage’s development efforts and will enable core research initiatives and the development of the innovative Sage Commons platform. 

Sage Bionetworks’ initial work will include generating integrated databases, creating tools for building and mining disease models and establishing governance rules for sharing, accessing and contributing to the data platform, all in the public domain. Sage’s concept is that human diseases could be cured more quickly and efficiently if academic and commercial researchers were able to access and integrate all available data. Mining these data should enable researchers to identify new drug targets relevant to disease biology. 

The Sage concept springs from work begun at Rosetta Inpharmatics, a subsidiary of Merck & Co.  As part of its efforts, Sage Bionetworks will be making previously proprietary genetics data and tools from Merck accessible to interested parties with no proprietary strings attached. Assembled over the past five-to-seven years, the Merck information represents one of the world’s most coherent set of genomic data tied with clinical trial outcomes. 

“There is a critical need to provide this access because genomic data has the potential to move the discovery side of the pharmaceutical industry away from the traditional competitive model toward consortium-style, pre-competitive collaborations,” said Sage Bionetworks President and CEO Stephen Friend, M.D., PhD.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing